Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...
Patent
1983-03-03
1984-09-11
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Parasitic organism or component thereof or substance...
A61K 3142
Patent
active
044709935
ABSTRACT:
Method of treating the central nervous system troubles such as the Parkinson's disease and the senescence troubles, generally treated by the B type monoamine oxidase inhibitors, which comprises administering internally to a human being requiring such treatment a therapeutically effective amount of N-aryl 5-aminomethyl oxazolidine-2-one derivatives.
REFERENCES:
"Differential Changes in Monoamine Oxidase A and B Activity in the Aging Rat Brain", Journal of Neurochemistry, 35(5):1026-1032, Nov., by M. STrolin Benedetti and P. E. Keane.
"Biogenic Amines in Human Brain in Normal Aging, Senile Dementia, and Chronic Alcoholism", Ergot Compounds and Brain Function: Neuroendocrine and Neuropsychiatric Aspects, 1980, pp. 295-304, by Arvid Carlsson et al.
"Selective Inhibition of B Type Monoamine Oxidase in the Brain: A Drug Strategy to Improve the Quality of Life in Senescence", Strategy in Drug Research, 1982, p. 107, by J. Knoll.
Ancher Jean-Francois R.
Bourgery Guy R.
Dostert Philippe L.
Douzon Colette A.
Guerret Patrick G.
Delalande S.A.
Friedman Stanley J.
LandOfFree
Therapeutical use of known 5-aminomethyl oxazolidine-2-one deriv does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutical use of known 5-aminomethyl oxazolidine-2-one deriv, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutical use of known 5-aminomethyl oxazolidine-2-one deriv will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1194588